Company / Shareholders' Equity
Thermo Fisher Scientific Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$53.4B
FY2025
5-year range
$40.8B / $53.4B
FY2021-FY2025
Trend
+7.7%
vs FY2024
Sector context
#3 of 161
Health Care
What the data says
Among 161 Health Care companies, Thermo Fisher Scientific is in the top 2% for shareholders' equity. Shareholders' Equity has increased for 9 consecutive years, from $21.5B in FY2016 to $53.4B in FY2025.
Based on SEC 10-K filings.
$53.4B in FY2025 with a 5-year CAGR of +9.1%. Ranks 3rd among 161 companies in Health Care.
Improved from $46.7B to $53.4B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +6.7%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 161This company $53.4B Sector average $5.1B
▼
+954.7% above sector average
Key checks
Key Insights
- Thermo Fisher Scientific's shareholders' equity has grown for 9 consecutive years.
- 5-year CAGR of +9.1%, indicating consistent growth.
- In FY2025, shareholders' equity increased 7.7% year-over-year.
- Ranks #3 out of 161 companies in the Health Care sector.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $53.4B | +7.7% |
| FY2024 | $49.6B | +6.1% |
| FY2023 | $46.7B | +6.3% |
| FY2022 | $44.0B | +7.8% |
| FY2021 | $40.8B | +18.2% |
| FY2020 | $34.5B | +16.3% |
| FY2019 | $29.7B | +7.6% |
| FY2018 | $27.6B | +8.6% |
| FY2017 | $25.4B | +18.0% |
| FY2016 | $21.5B | +0.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026